Valhi, Inc.

TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the launch of VitalHub AI Scribe, an ambient clinical intelligence (“ACI”) solution that captures conversations, identifies clinically relevant information, and automatically generates documentation, including case notes, transcriptions, client summaries, and patient summaries.

Shares of Vitalhub Corp. (TSE: VHI - Get Free Report) have received a consensus rating of "Buy" from the six ratings firms that are covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price

VHI's Q2 earnings jump y/y as higher TiO2 volumes, lower costs and wider margins lift the results, supporting an improved 2026 operating outlook.

TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (“VitalHub” or the “Company”) announced today that the Toronto Stock Exchange (the "Exchange") has accepted a notice filed by VitalHub of its intention to make a Normal Course Issuer Bid (the "Bid") to be transacted through the facilities of the Exchange or through alternative Canadian trading systems.